Where can I buy lxrx stock?
Shares of LXRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Who bought Lexicon Pharmaceuticals stock?
Company insiders that have bought Lexicon Pharmaceuticals stock in the last two years include Alexander A Santini, Christopher J Sobecki, and Lonnel Coats. View insider buying and selling activity for Lexicon Pharmaceuticals or or view top insider-buying stocks. How do I buy shares of Lexicon Pharmaceuticals?
Is lxrx a sell or buy on Robinhood?
Today LXRX ranks #11079 as sell candidate. Get a Free Stock at Robinhood Which way will LXRX go? * StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
Is Lxrx a good stock to buy?
The consensus among 1 Wall Street analyst covering (NASDAQ: LXRX) stock is to Strong Buy LXRX stock.
Will Lxrx stock go up?
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) The 2 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 12.50, with a high estimate of 20.00 and a low estimate of 5.00. The median estimate represents a +305.84% increase from the last price of 3.08.
Should I buy or sell Lexicon Pharmaceuticals stock right now?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lexicon Pharmaceuticals in the last year. There are currently 1 b...
What is Lexicon Pharmaceuticals' stock price forecast for 2022?
1 equities research analysts have issued 1-year target prices for Lexicon Pharmaceuticals' shares. Their forecasts range from $20.00 to $20.00. On...
How has Lexicon Pharmaceuticals' stock price performed in 2022?
Lexicon Pharmaceuticals' stock was trading at $3.94 at the start of the year. Since then, LXRX stock has decreased by 60.9% and is now trading at $...
When is Lexicon Pharmaceuticals' next earnings date?
Lexicon Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Friday, July 29th 2022. View our earnings forecast for...
How were Lexicon Pharmaceuticals' earnings last quarter?
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) posted its earnings results on Thursday, May, 5th. The biopharmaceutical company reported ($0.16) earni...
Who are Lexicon Pharmaceuticals' key executives?
Lexicon Pharmaceuticals' management team includes the following people: Mr. Lonnel Coats , CEO & Director (Age 57, Pay $1.14M) Mr. Jeffrey L. Wa...
What is Lonnel Coats' approval rating as Lexicon Pharmaceuticals' CEO?
9 employees have rated Lexicon Pharmaceuticals CEO Lonnel Coats on Glassdoor.com . Lonnel Coats has an approval rating of 100% among Lexicon Pharm...
Who are some of Lexicon Pharmaceuticals' key competitors?
Some companies that are related to Lexicon Pharmaceuticals include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Rege...
What other stocks do shareholders of Lexicon Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Lexicon Pharmaceuticals investors own include Portola Phar...
When will Lexicon Pharmaceuticals release its earnings?
How much does Lexicon Pharmaceuticals make?
Lexicon Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021. View our earnings forecast for Lexicon Pharmaceuticals.
Nasdaq Global Select
How much money does Lexicon Pharmaceuticals make? Lexicon Pharmaceuticals has a market capitalization of $493.81 million and generates $24 million in revenue each year. The biopharmaceutical company earns $-58,570,000.00 in net income (profit) each year or ($0.52) on an earnings per share basis.
Environmental, Social, and Governance Rating
A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
How much did Lexicon stock fall in 2021?
A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.
Is LXRX upside or downside?
The Lexicon Pharmaceuticals stock price fell by -2.99% on the last day (Wednesday, 7th Jul 2021) from $4.01 to $3.89. and has now fallen 8 days in a row. During the day the stock fluctuated 6.72% from a day low at $3.80 to a day high of $4.05. The price has fallen in 7 of the last 10 days and is down by -16.88% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -60 thousand shares and in total, 857 thousand shares were bought and sold for approximately $3.33 million.
Premium Research for LXRX
JPMorgan Chase & Co. does not see either upside or downside right now giving LXRX "Underweight - Neutral" on their last update on January 29, 2021. The price target was set to $7.00 .
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.